Skip to main content

Opus Genetics, Inc.

IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001228627

In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Opus Genetics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of IRD: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders4859+11
Shares19.0M27.8M+8.78M (+46.1%)
Value$31.9M$55.9M+$24.0M (+75.1%)

New holders (16)

Institutions that held Opus Genetics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IRD in Q4 2025
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC2,718,029$5.46M0.01%
Millennium Management LLC2,002,550$4.03M0.00%
Marshall Wace, LLP157,648$316.9K0.00%
Omers Administration Corp87,900$176.7K0.00%
Texas Capital Bank Wealth Management Services Inc78,000$156.8K0.01%
Regency Capital Management Inc.46,000$92.5K0.04%
ADAR1 Capital Management, LLC40,000$80.4K0.01%
Qube Research & Technologies Ltd39,978$80.4K0.00%
Johnson Investment Counsel Inc20,000$40.2K0.00%
Virtu Financial LLC16,810$34.0K0.00%
Occudo Quantitative Strategies LP12,205$24.5K0.00%
First City Capital Management, Inc.11,836$23.8K0.01%
Miller Financial Services LLC10,000$20.1K0.02%
Hilton Head Capital Partners, LLC4,472$8.99K0.01%
International Assets Investment Management, LLC521$1.05K0.00%
Allworth Financial LP5$110.00%

Sold out (5)

Institutions that held Opus Genetics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IRD in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
HRT Financial LP20,677$34.0K
Two Sigma Securities, LLC17,746$29.3K
Prudential Financial Inc13,100$21.6K
Two Sigma Advisers, LP10,200$16.8K
MAI Capital Management123$203